Latest / Investor Exchange / Quantum Healthcare HY2025 Financial Results

Transcript

Quantum Healthcare HY2025 Financial Results · Investor Exchange

• 0:02
  Time for another Investor Exchange podcast. Here are your hosts, Matt and Sally.
• 0:08
  Welcome back to The Deep Dive, your shortcut to being well-informed.
• 0:11
  Today, our mission is to unravel the recent financial performance of Quantum Healthcare Limited.
• 0:17
  And right off the bat, we got something pretty unusual.
• 0:20
  Their auditors have issued a disclaimer of opinion for the past three financial years.
• 0:25
  So this isn't just a routine financial update, quantum health care is specifically
• 0:29
  required to announce these half year 2025 results because of that ongoing disclaimer.
• 0:34
  Yeah, that's right. That itself is a pretty significant signal telling us there's
• 0:38
  a fascinating, maybe complex story unfolding here. Absolutely.
• 0:42
  That disclaimer immediately tells us there's a story far beyond just the numbers themselves.
• 0:48
  It signals, you know, an inherent complexity in their financial landscape.
• 0:51
  So our analysis of their current health, the why behind it and their future
• 0:55
  outlook becomes even more crucial.
• 0:56
  For anyone looking to truly understand their position, it really demands a careful
• 1:01
  look at their operational and strategic moves.
• 1:03
  Definitely. Okay, so let's dive straight into the core financial results.
• 1:06
  We're looking at the three and six months ended June 30th, 2025 compared to last year.
• 1:12
  And surprisingly, the initial glance at the profit and loss statement actually
• 1:16
  holds some genuinely positive shifts. So let's start with revenue.
• 1:20
  It saw, well, a healthy jump, over 2.5% for the quarter, climbing to S3.2 million.
• 1:27
  And over the full half year, that increase was even stronger,
• 1:30
  up 4.2%, pushing them past $6.3 million.
• 1:34
  That's a good, solid start on the top line, wouldn't you say?
• 1:37
  Yeah, that's definitely positive
• 1:38
  movement. And that trend, it directly translates to gross profit as well.
• 1:42
  For the quarter, gross profit rose by about 4.5%, reaching S1.45 million.
• 1:46
  And over the half year, the improvement was even better, climbing nearly 8%
• 1:50
  to $2.9 million. So following the revenue nicely.
• 1:53
  Okay, but here's the real headline, I think, from their P&L.
• 1:55
  Quantum Healthcare has slashed its losses significantly.
• 1:58
  We're talking about a near 40% reduction in their quarterly loss before tax.
• 2:03
  That brings it down to roughly $265,000.
• 2:07
  And for the full half year, that improvement is even more dramatic.
• 2:11
  An incredible 59% reduction. It shrinks their loss to just $385,000.
• 2:18
  This isn't just a minor tweak, right? It feels like a profound,
• 2:21
  positive shift in their financial picture.
• 2:23
  Oh, absolutely. That kind of progress, even before reaching full profitability,
• 2:27
  is a critical milestone.
• 2:28
  It strongly suggests their underlying strategies, the efforts to improve performance,
• 2:33
  are having a tangible, significant impact.
• 2:35
  It signals a potential shift in their operational trajectory.
• 2:38
  It really indicates that the efforts to turn things around are,
• 2:41
  well, starting to bear fruit.
• 2:43
  That is a powerful indicator of progress. But the big question is how?
• 2:47
  How did Quantum Healthcare manage such a significant turnaround in their losses?
• 2:51
  Especially when, like we said, we started this deep dive with that auditor's
• 2:54
  disclaimer hanging over them. Let's peel back the layers and understand the why. Right.
• 2:58
  Well, the management commentary sheds a lot of light on the drivers here.
• 3:01
  The primary reason for that revenue growth we just talked about was the start
• 3:05
  of operations at their new clinic, TDH Seng Kang. That opened back in July 2024.
• 3:11
  So this new addition directly boosted their healthcare business segment.
• 3:15
  And naturally, the gross profit improvement followed that increased revenue.
• 3:19
  Makes sense. Okay, so new clinic driving revenue.
• 3:22
  Got it. But it wasn't just about growing the top line. They also took a kind
• 3:26
  of comprehensive approach to cost management.
• 3:29
  Administrative expenses saw a notable decrease. This is across several areas.
• 3:34
  Less staff costs for the company itself, reduced professional fees,
• 3:37
  and lower depreciation expenses on their plant and equipment,
• 3:39
  and also their right-of-use assets.
• 3:41
  That's basically their office and clinic leases. On top of that,
• 3:44
  their finance costs decreased, mainly due to less interest incurred on their bank loans and leases.
• 3:50
  Even other income saw a slight dip, mostly fewer government grants.
• 3:54
  But interestingly, that was offset by higher rental income they received.
• 3:57
  Huh. So it's a multifaceted, attack-boosting revenue with the new clinic and
• 4:02
  cutting costs pretty broadly.
• 4:04
  It's fascinating how a single new clinic can make such a difference.
• 4:08
  It really highlights the deliberate focus on the health care business,
• 4:11
  doesn't it? Seems like that's where the growth story truly is. It absolutely is.
• 4:15
  And when we delve into the operating segments, this focus becomes even clearer.
• 4:19
  The health care business segment is, well, it's the undeniable engine of their current performance.
• 4:24
  For the six months, this segment alone generated a profit before tax of $60,000.
• 4:29
  And critically, all of the external revenue, that $6.3 million plus for the
• 4:34
  six months, came from this segment. Wow, all of it.
• 4:37
  All of it. Then, on the flip side, you've got the legacy vascular business.
• 4:42
  Now, this actually ceased operations back in FY 2021.
• 4:47
  But it still reported segment losses. This is apparently due to certain interests
• 4:52
  and contingent liabilities.
• 4:54
  They still retain from that old operation. And then you have the corporate segment.
• 4:57
  As the investment holding company, it significantly contributed to the overall group losses.
• 5:02
  So you're really seeing a tale of two very different operational stories within one company.
• 5:08
  The healthcare business is driving forward, while legacy issues and corporate
• 5:12
  overhead continue to be, well, a drag.
• 5:15
  That segmentation truly paints a much clearer picture. You can see exactly where
• 5:19
  the company's energy and future are directed.
• 5:21
  All right, let's switch gears now. Let's turn to the balance sheet,
• 5:24
  what the company owns and owes, and then look at how cash is actually moving through the business.
• 5:28
  Because, you know, reducing losses is one thing, but how stable is the financial
• 5:32
  foundation itself? Good question.
• 5:34
  Looking at the statements of financial position, comparing June 30,
• 5:37
  2025 to the end of last year, December 31, 2024, we see total assets decreased.
• 5:43
  They went down by 7.7%, falling from about $12.5 million to $11.5 million.
• 5:51
  This was primarily due to declines in non-current assets.
• 5:54
  Think depreciation on plant and equipment, amortization of intangible assets,
• 5:59
  reductions in those right-of-use assets.
• 6:01
  Current assets also decreased, mainly cash and trade receivables because of
• 6:04
  slower collections, although that was slightly cushioned by an increase in inventories.
• 6:08
  Okay, assets down. What about the other side, liabilities? Total liabilities
• 6:12
  also saw a decrease, down by 3.7%. They moved from $15.5 million to $14.9 million.
• 6:18
  Now, this is mainly due to a decrease in non-current liabilities,
• 6:21
  so longer-term stuff like lease and loan repayments.
• 6:24
  However, current liabilities, the short-term ones, actually saw a slight increase,
• 6:27
  primarily from trade and other payables.
• 6:29
  And the commentary says this grew because they negotiated with creditors to
• 6:32
  basically extend payment terms further, kicking the can down the road a bit, perhaps. Hmm.
• 6:36
  Okay. And here's a really critical point, I think, that reveals the depth of
• 6:40
  their financial challenge.
• 6:42
  The group still reports a deficit in shareholders' equity of over US$3.3 million.
• 6:48
  Now, for our listeners, that means the company's total liabilities actually
• 6:52
  outweigh all its assets and capital contributions.
• 6:56
  Essentially, they're in a financial hole that's actually gotten a bit deeper
• 6:59
  since year end. That's a tough spot to be in.
• 7:01
  It is. And what's more, they're reporting a significant negative working capital
• 7:05
  of $8.7 million, which means their short-term liabilities massively exceed their short-term assets.
• 7:13
  That poses a real challenge for meeting immediate obligations.
• 7:16
  Exactly. Negative working capital of that magnitude is a serious concern for liquidity.
• 7:21
  Okay, so that's quite a bit to unpack there. While the losses are down,
• 7:24
  which is good news, the overall financial position still shows some significant
• 7:28
  hurdles like that growing equity deficit and the big negative working capital.
• 7:32
  So how is cash actually flowing through the company given these circumstances,
• 7:37
  are they managing to generate enough cash to, well, stay afloat?
• 7:40
  Right. Let's look at the cash flow statement for the six months ended June 30,
• 7:43
  2025. This gives us that answer.
• 7:46
  What's encouraging, actually, is that they generated positive cash from operating
• 7:51
  activities about S1 million dollars.
• 7:53
  This was supported partly by their operating profit improvements,
• 7:56
  but also by movements in working capital, specifically those slower collections
• 8:01
  from customers we mentioned, and also the extended payment terms they got from creditors.
• 8:06
  So managing working capital helped generate cash here.
• 8:09
  Operationally, that's a good sign. Okay. Positive from operations.
• 8:12
  That's key. It is. Now, cash used in investing activities was minimal.
• 8:16
  Just $3,000, mainly for buying some plant and equipment. Small potatoes.
• 8:21
  However, the picture changes significantly when we look at financing activities.
• 8:24
  Here, the company used a substantial S1.18 million dollars in cash. Why?
• 8:28
  Well, mainly due to repaying loan borrowings, that was $524,000,
• 8:32
  and repaying lease liabilities, which cost them S660,000 dollars. Ah.
• 8:37
  So the debt and lease payments are pretty hefty. They are. And what truly stands
• 8:42
  out here is the net result.
• 8:44
  Despite generating that positive S1 million dollars from operations,
• 8:49
  the company's overall cash balance still declined by S187 thousand dollars over the six months.
• 8:55
  So that tells us their financing obligations.
• 8:58
  The loan and lease repayments are substantial. They're basically consuming a
• 9:01
  significant chunk of those operational gains.
• 9:04
  Right. So the cash generated by actually running the business is immediately
• 9:08
  being channeled into servicing debt and leases rather than building up any kind of buffer. Precisely.
• 9:13
  It highlights the pressure they're under from those liabilities.
• 9:15
  That puts a fine point on it, highlighting the constant juggle they're facing.
• 9:19
  And this brings us directly, I think, to the elephant in the room.
• 9:23
  The material uncertainty regarding the group's ability to continue as a going concern.
• 9:27
  This is explicitly stated in note 2.1 of their financials. This is,
• 9:31
  you know, a critical indicator.
• 9:33
  It means the company itself is stating there's a real question mark over their
• 9:36
  ability to continue operating long term. Indeed.
• 9:39
  A going concern assumption basically means a company is expected to keep operating
• 9:43
  for the foreseeable future, usually at least the next 12 months.
• 9:48
  And given those ongoing auditor disclaimers, coupled with the negative working
• 9:52
  capital we just discussed, that S8.7 million dollars, and that increasing deficit
• 9:58
  in shareholders' equity of S3.3 million dollars,
• 10:02
  well, it's clear why this is flagged as a material uncertainty.
• 10:06
  It's a combination of factors pointing to financial stress.
• 10:09
  So how are they planning to navigate this? What makes the directors think the
• 10:12
  going concern assumption is still appropriate? Right.
• 10:15
  They do believe it's appropriate based on a specific plan they've laid out. It has several parts.
• 10:19
  First, they anticipate securing an additional loan of S-300,000 from a shareholder
• 10:24
  and a director. So new funding injection expected.
• 10:27
  Second, they're apparently not expecting to pay certain legal fees,
• 10:30
  which are currently sitting there as liabilities.
• 10:32
  Details maybe weren't fully provided on why, but that's part of the plan.
• 10:35
  Third, they've obtained formal undertaking letters, basically promises from
• 10:40
  a director and a shareholder to defer payment of their loans.
• 10:43
  These loans total around S-454,000 dollars combined, and the deferral is for
• 10:49
  18 months, starting from February 28, 2025.
• 10:54
  Pushing those payments out. Okay, deferrals are key then. Very key.
• 10:57
  Fourth, another related company has also provided an undertaking not to demand
• 11:01
  payment for its substantial loan over S1.7 million dollars again for 18 months
• 11:05
  from that same date, February 28, 2025.
• 11:08
  So significant support from related parties and insiders through these deferrals.
• 11:12
  And fifth, they are banking heavily on the positive cash inflow from their healthcare businesses.
• 11:17
  They expect these to continue being profitable and generate positive cash flows to support operations.
• 11:22
  And finally, management says they're committed to ongoing comprehensive cost-cutting
• 11:26
  measures and they're actively exploring new business opportunities and fundraising exercises.
• 11:30
  So keep looking for ways to approve and bring in cash.
• 11:33
  It really is a complex web, isn't it? Financial maneuvers, relying on related
• 11:37
  parties, banking on the core business.
• 11:39
  And it's probably worth noting the context of those legal proceedings we touched on earlier.
• 11:43
  There was that Anora dispute, which led to a huge provision for settlement costs
• 11:47
  booked at the end of 2023 over S3.8 million dollars in total.
• 11:52
  But the good news for this period, HY 2025, is that no further significant provisions were needed.
• 11:58
  That came after Anora filed for dismissal of the complaint back in November 2024.
• 12:03
  So that's at least one less major potential financial drain hanging over them right now. Absolutely.
• 12:09
  Resolving that particular legal uncertainty is a clear positive step.
• 12:12
  It removes a big potential liability. But the broader implication here regarding
• 12:16
  the going concern plan is that while management has laid out these steps,
• 12:20
  the financials explicitly state these considerations are premised on future
• 12:24
  events, which are inherently uncertain.
• 12:26
  Ah, the standard disclaimer, but very relevant here.
• 12:28
  Very relevant. It just underscores the delicate balance the company is trying
• 12:33
  to maintain, their ability to actually secure that additional funding,
• 12:36
  and for those deferrals to hold firm. It's absolutely crucial.
• 12:41
  Any misstep there, or if the healthcare business doesn't perform as expected,
• 12:44
  could significantly alter their trajectory. Indeed.
• 12:48
  A lot hinges on those future events. Okay, so looking forward then,
• 12:52
  what can we expect from quantum healthcare in the next year or so,
• 12:57
  according to their own outlook statement?
• 12:59
  What's the strategic focus moving ahead, you know, to navigate these challenges?
• 13:04
  Well, the company's stated outlook indicates a sort of cautious stability.
• 13:08
  They use the standard phrasing.
• 13:09
  Barring any unforeseen circumstances, there are no known significant changes
• 13:13
  in the trends and competitive conditions. and no other major known factors or
• 13:17
  events that may adversely affect the group in the next 12 months.
• 13:20
  So that's a relatively neutral baseline expectation, not signaling major new
• 13:25
  problems, but not exactly forecasting explosive growth either.
• 13:29
  Kind of a steady-as-she-goes vibe while they work on the plan. Pretty much.
• 13:33
  Strategically, they emphasize they continue to actively explore various strategic
• 13:38
  options and fundraising opportunities, which, of course, directly ties into
• 13:43
  addressing those going concern issues we just discussed.
• 13:46
  And their core focus remains squarely on that health care business.
• 13:50
  They talk about continuous efforts to streamline their dental clinic operations
• 13:53
  for greater efficiency and crucially to grow this segment, which,
• 13:58
  again, they explicitly expect to be profitable and cash flow positive. Yeah.
• 14:02
  That's where they see the solution coming from. So it really seems clear their
• 14:05
  future hinges heavily on the continued success and growth of that health care
• 14:09
  business. And alongside that, their ability to secure the needed funding and
• 14:13
  make those debt deferrals stick.
• 14:14
  Their focus seems laser sharp on that path, hoping, I guess,
• 14:18
  that the momentum from their dental clinics can outpace and eventually resolve
• 14:22
  those lingering significant financial obligations.
• 14:25
  Yeah, that sums it up well. In the grand scheme, the outlook is,
• 14:29
  let's say, cautiously optimistic.
• 14:32
  But it's heavily reliant on the successful execution of those strategic initiatives
• 14:37
  and, of course, the sustained positive performance of their health care segment.
• 14:41
  Those legacy issues, while seeing some improvement like the legal dismissal
• 14:45
  and the debt deferrals, they remain a significant background factor.
• 14:50
  It makes a successful implementation of their growth and financing plans absolutely
• 14:54
  critical for their long-term viability. It's a real balancing act they're performing.
• 14:59
  Okay, so let's wrap this up. Today, you've gotten a truly deep dive into Quantum
• 15:03
  Healthcare's latest financials.
• 15:05
  We've seen some really significant reductions in losses, which is great news,
• 15:09
  largely driven by their growing healthcare business and some aggressive cost-cutting.
• 15:13
  But we've also uncovered that critical-going concern challenge,
• 15:16
  which they're actively trying to address through a whole series of moves.
• 15:19
  Debt deferrals, expected shareholder loans, and that sharp strategic pivot towards
• 15:23
  their profitable dental services. And remember, you know, in the world of finance,
• 15:27
  even a loss on the books can tell a story of significant improvement and strategic
• 15:31
  redirection, like we saw here.
• 15:33
  The steps Quantum Healthcare is taking are definitely ambitious,
• 15:37
  and their success is really going to be a testament to their focused efforts
• 15:41
  in that healthcare sector.
• 15:42
  It's a dynamic situation, you know, where management's proactive measures are
• 15:46
  absolutely central to navigating some pretty serious financial headwinds.
• 15:50
  So what does this all mean for you, the listener?
• 15:53
  Well, it means that even when a company faces what's called material uncertainty,
• 15:57
  it can still be actively charting a new determined course.
• 16:01
  It shows resilience and strategic focus.
• 16:04
  The big question, though, remains, how quickly can their health care momentum
• 16:08
  actually outpace those lingering financial obligations and uncertainties?
• 16:13
  Keep a close eye on those dental clinics. They really do seem to be the key
• 16:17
  to quantum health care's future path.
• 16:18
  Music.